Unknown

Dataset Information

0

Regulation of cell migration and survival by focal adhesion targeting of Lasp-1.


ABSTRACT: Large-scale proteomic and functional analysis of isolated pseudopodia revealed the Lim, actin, and SH3 domain protein (Lasp-1) as a novel protein necessary for cell migration, but not adhesion to, the extracellular matrix (ECM). Lasp-1 is a ubiquitously expressed actin-binding protein with a unique domain configuration containing SH3 and LIM domains, and is overexpressed in 8-12% of human breast cancers. We find that stimulation of nonmotile and quiescent cells with growth factors or ECM proteins facilitates Lasp-1 relocalization from the cell periphery to the leading edge of the pseudopodium, where it associates with nascent focal complexes and areas of actin polymerization. Interestingly, although Lasp-1 dynamics in migratory cells occur independently of c-Abl kinase activity and tyrosine phosphorylation, c-Abl activation by apoptotic agents specifically promotes phosphorylation of Lasp-1 at tyrosine 171, which is associated with the loss of Lasp-1 localization to focal adhesions and induction of cell death. Thus, Lasp-1 is a dynamic focal adhesion protein necessary for cell migration and survival in response to growth factors and ECM proteins.

SUBMITTER: Lin YH 

PROVIDER: S-EPMC2172195 | biostudies-literature | 2004 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Regulation of cell migration and survival by focal adhesion targeting of Lasp-1.

Lin Yi Hsing YH   Park Zee-Yong ZY   Lin Dayin D   Brahmbhatt Anar A AA   Rio Marie-Christine MC   Yates John R JR   Klemke Richard L RL  

The Journal of cell biology 20040501 3


Large-scale proteomic and functional analysis of isolated pseudopodia revealed the Lim, actin, and SH3 domain protein (Lasp-1) as a novel protein necessary for cell migration, but not adhesion to, the extracellular matrix (ECM). Lasp-1 is a ubiquitously expressed actin-binding protein with a unique domain configuration containing SH3 and LIM domains, and is overexpressed in 8-12% of human breast cancers. We find that stimulation of nonmotile and quiescent cells with growth factors or ECM protein  ...[more]

Similar Datasets

| S-EPMC5476826 | biostudies-literature
| S-EPMC8101467 | biostudies-literature
| S-EPMC4683442 | biostudies-literature
| S-EPMC3244064 | biostudies-literature
| S-EPMC3376739 | biostudies-literature
| S-EPMC5681678 | biostudies-literature
| S-EPMC6149462 | biostudies-literature
| S-EPMC8115569 | biostudies-literature
| S-EPMC3661225 | biostudies-literature
| S-EPMC1223245 | biostudies-other